[go: up one dir, main page]

AU3340797A - Modified oligonucleotides - Google Patents

Modified oligonucleotides

Info

Publication number
AU3340797A
AU3340797A AU33407/97A AU3340797A AU3340797A AU 3340797 A AU3340797 A AU 3340797A AU 33407/97 A AU33407/97 A AU 33407/97A AU 3340797 A AU3340797 A AU 3340797A AU 3340797 A AU3340797 A AU 3340797A
Authority
AU
Australia
Prior art keywords
modified oligonucleotides
oligonucleotides
modified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU33407/97A
Inventor
Alain De Mesmaeker
Jacques Lebreton
Sebastian Wendeborn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG, Novartis AG filed Critical Ciba Geigy AG
Publication of AU3340797A publication Critical patent/AU3340797A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU33407/97A 1996-06-28 1997-06-19 Modified oligonucleotides Abandoned AU3340797A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP96810431 1996-06-28
EP96810431 1996-06-28
PCT/EP1997/003192 WO1998000434A1 (en) 1996-06-28 1997-06-19 Modified oligonucleotides

Publications (1)

Publication Number Publication Date
AU3340797A true AU3340797A (en) 1998-01-21

Family

ID=8225638

Family Applications (1)

Application Number Title Priority Date Filing Date
AU33407/97A Abandoned AU3340797A (en) 1996-06-28 1997-06-19 Modified oligonucleotides

Country Status (3)

Country Link
AU (1) AU3340797A (en)
WO (1) WO1998000434A1 (en)
ZA (1) ZA975742B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10238722A1 (en) 2002-08-23 2004-03-11 Bayer Ag Improving attention, concentration, cognition, learning and/or memory performance, using selective phosphodiesterase 9A inhibitors, preferably 4H-pyrazolo-(3,4-d)-pyrimidin-4-one derivatives
PE20091211A1 (en) 2007-11-30 2009-09-14 Boehringer Ingelheim Int PYRAZOLOPYRIMIDINE DERIVATIVES AS PDE9A MODULATORS
UA105362C2 (en) 2008-04-02 2014-05-12 Бьорингер Ингельхайм Интернациональ Гмбх 1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
WO2010026214A1 (en) 2008-09-08 2010-03-11 Boehringer Ingelheim International Gmbh Pyrazolopyrimidines and their use for the treatment of cns disorders
JP5763539B2 (en) 2008-10-24 2015-08-12 アイシス ファーマシューティカルズ， インコーポレーテッド 5 'and 2' bis-substituted nucleosides and oligomeric compounds produced therefrom
WO2010048585A2 (en) 2008-10-24 2010-04-29 Isis Pharmaceuticals, Inc. Oligomeric compounds and methods
PE20120505A1 (en) 2009-03-31 2012-05-09 Boehringer Ingelheim Int DERIVATIVES OF 1-HETEROCICLIL-1,5-DIHIDRO-PIRAZOLO [3,4-D] PYRIMIDIN-4-ONA AS MODULATORS OF PDE9A
WO2011139702A2 (en) 2010-04-28 2011-11-10 Isis Pharmaceuticals, Inc. Modified nucleosides and oligomeric compounds prepared therefrom
US9127033B2 (en) 2010-04-28 2015-09-08 Isis Pharmaceuticals, Inc. 5′ modified nucleosides and oligomeric compounds prepared therefrom
HUE033378T2 (en) 2010-08-12 2017-11-28 Boehringer Ingelheim Int 6-Cycloalkyl-1,5-dihydro-pyrazolo [3,4-D] pyrimidin-4-one and their use as PDE9A inhibitors
AP3584A (en) 2010-09-22 2016-02-09 Alios Biopharma Inc Substituted nucleotide analogs
US8809345B2 (en) 2011-02-15 2014-08-19 Boehringer Ingelheim International Gmbh 6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders
CA2860234A1 (en) 2011-12-22 2013-06-27 Alios Biopharma, Inc. Substituted phosphorothioate nucleotide analogs
US8916538B2 (en) 2012-03-21 2014-12-23 Vertex Pharmaceuticals Incorporated Solid forms of a thiophosphoramidate nucleotide prodrug
EP2827876A4 (en) 2012-03-22 2015-10-28 Alios Biopharma Inc Pharmaceutical combinations comprising a thionucleotide analog
GB201700595D0 (en) * 2017-01-13 2017-03-01 Univ Oxford Innovation Ltd Oligonucleotide ligation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378825A (en) * 1990-07-27 1995-01-03 Isis Pharmaceuticals, Inc. Backbone modified oligonucleotide analogs
US6066447A (en) * 1994-01-26 2000-05-23 Novartis Corporation Modified oligonucleotides
EP0714907A1 (en) * 1994-11-30 1996-06-05 F. Hoffmann-La Roche Ag Oligoribonucleotides with amide backbone

Also Published As

Publication number Publication date
ZA975742B (en) 1997-12-29
WO1998000434A1 (en) 1998-01-08

Similar Documents

Publication Publication Date Title
AU4040197A (en) Microturbomachinery
AU3387997A (en) Autonotification
AU2845197A (en) Cycloalkano-pyridines
AU4945197A (en) Aminothiophenecarboxamides
AU4013397A (en) Arylalkanoylpyridazines
AU2684197A (en) Handleset
AU4176997A (en) 3-alkyl-3-phenyl-piperidines
AU5754898A (en) Ussd-positioning
AU4218597A (en) Superseat
AU3340797A (en) Modified oligonucleotides
AU5556998A (en) 3-amino-1-cyanophenyl-uracils
AU2090897A (en) Hydroxyhexahydropyridazines
AU5221598A (en) Sweet-toy
AU3130597A (en) Tristetraprolin
AU2237197A (en) Fishing-lure
AU686068B2 (en) Cremators
AU4332497A (en) Endo-beta-galactosidase
AU5983798A (en) Heterocyclyluracils
AU1597197A (en) Thienoquinolines
AU5002897A (en) Gripper-accumulator
AU7623898A (en) Tri-pocket
AU3557397A (en) Double-tau-profile
AU5754598A (en) Heterocyclyluracils
AU2696897A (en) Modified oligonucleotides
AU5314999A (en) Modified oligonucleotides